Skip to content
  • English
  • French
Menu
  • About
    • ACT Operations Committee
    • Our Consortium
      • Our Portfolio Hospitals
      • Clinical Trial Units
      • Research Networks
    • Our Committees
    • Commitment to Equity, Diversity, Inclusion & Indigeneity
  • Funded Projects
    • New Networks
    • Library
  • Resources
    • Education
    • Patient Engagement
    • Community Hospital Resources
    • Calls to Action
    • Meetings
      • ACT Cape Breton Conference
  • ACT Contracts
    • gDSSA
    • Sub-Site Template
    • gPSA Regulated
    • g-PSA Non-Regulated
  • Contact
  • Call for Networks

Call for Networks to join ACT 2 Grant Application

To enhance the impact of trial networks in Canada, ACT is holding a call for networks to join the ACT-2

Read More

KM RFA Announcement

The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices.

Read More

RFA 5 Announcement

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were

Read More

Group Selected to Run Pan-Canadian Single Research Ethics Board Review Process

International review panel selects CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with

Read More

Canadian Biotech Opportunity

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we

Read More

New Pan-Canadian Data and Sample Transfer Agreement

New pan-Canadian data and sample transfer agreement a game-changer for clinical research “We’ve built a high-speed legal highway for researchers

Read More

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.